| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | FENNEC PHARMACEUTICALS INC. | 1.76% | 1.27% | 31.14% | -26.50% | 44.25% | 145 |
| | | | | | | |
| GILEAD SCIENCES, INC. | -0.21% | 7.77% | -13.65% | -7.39% | -7.19% | 79 122 |
| VERTEX PHARMACEUTICALS | -3.28% | 11.20% | 26.54% | 40.48% | 51.54% | 74 821 |
| REGENERON PHARMACEUTICALS, INC. | -1.21% | 5.43% | -5.77% | 9.66% | 90.13% | 65 993 |
 | WUXI APPTEC CO., LTD. | -1.27% | 8.96% | -13.86% | -34.77% | 176.13% | 44 742 |
| BIONTECH SE | -2.58% | 7.11% | -45.69% | -38.71% | --.--% | 32 574 |
 | GENMAB A/S | -1.32% | 12.25% | -14.75% | -14.23% | 85.75% | 20 738 |
 | ARGENX SE | -1.65% | 1.60% | 9.83% | 29.89% | 181.09% | 19 381 |
| BEIGENE, LTD. | -5.27% | 34.70% | -40.11% | -54.68% | 30.90% | 18 382 |
| NEUROCRINE BIOSCIENCES, INC. | -2.65% | 5.32% | 14.22% | -1.06% | 15.22% | 9 389 |
| LEGEND BIOTECH CORPORATION | -1.38% | 14.34% | 11.17% | 26.10% | --.--% | 8 153 |
| EXELIXIS, INC. | -5.90% | 19.72% | 14.39% | 16.04% | -2.15% | 7 127 |
| SAREPTA THERAPEUTICS, INC. | -2.52% | 12.32% | -17.40% | -7.92% | -51.05% | 6 582 |
| HALOZYME THERAPEUTICS, INC. | -1.47% | 6.25% | 15.27% | 0.85% | 169.79% | 6 462 |
| INTRA-CELLULAR THERAPIES, INC. | -3.51% | 1.24% | 6.74% | 38.88% | 330.43% | 5 246 |
| ASCENDIS PHARMA A/S | -1.95% | 8.54% | -30.69% | -31.89% | -19.02% | 5 084 |
| | | | | | | |
| | Durchschnitt | -2.41% | 10.45% | -5.58% | -1.92% | 80.89% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -1.91% | 9.52% | -5.56% | -0.36% | 70.23% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
